Restructuring of the China business and transfer of Wuhan functions to Guangzhou
First written in FY2025-H1. 5 of 6 entries say "Advanced", first in FY2025. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Business restructuring expenses consist of economic compensation payments arising from workforce rationalization carried out in connection with the restructuring of the China business.」
The company continued workforce rationalization in connection with the restructuring of the China business and recognized ¥3.933 million in business restructuring expenses in the current period. The nature of the expenses has been reorganized as workforce rationalization costs, compared with the previous period's costs related to the closure of the Wuhan office. - FY2026-H1AdvancedAnnual report
「The segment loss was ¥42 million, compared with a segment loss of ¥92 million in the same period of the previous year. Although expenses declined as a result of the restructuring carried out in the previous fiscal year, the impact of lower sales was greater than the reduction in expenses.」
The benefits of lower expenses from the restructuring carried out in the previous fiscal year in connection with the China business restructuring emerged, narrowing the China segment loss from ¥92 million to ¥42 million. However, the impact of lower revenue continues. - FY2025AdvancedAnnual report
「Business restructuring expenses consist of economic compensation payments arising from workforce rationalization carried out in connection with the restructuring of the China business, penalties for terminating the lease of rented warehouses following the closure of the Wuhan office, and other costs.」
Costs related to workforce rationalization and the closure of the Wuhan office were incurred in connection with the restructuring of the China business, and business restructuring expenses of ¥50.714 million were recognized. - FY2025-H1First statedAnnual report
「At a meeting held on 5 November 2024, the Board of Directors resolved to close the Wuhan branch of the consolidated subsidiary 大橋精密件（上海）有限公司 at the end of December 2024, in light of the reduction in production capacity among Japanese automakers in China, and to transfer its functions to the consolidated subsidiary 大橋汽車配件（広州）有限公司.」
In light of the reduction in production capacity among Japanese automakers in China, the company disclosed for the first time a restructuring policy to close the Wuhan branch in December 2024 and transfer its functions to the Guangzhou subsidiary. The impact on consolidated results is still under review.